HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

In vitro models to study insulin and glucocorticoids modulation of trimethyltin (TMT)-induced neuroinflammation and neurodegeneration, and in vivo validation in db/db mice.

Abstract
Brain susceptibility to a neurotoxic insult may be increased in a compromised health status, such as metabolic syndrome. Both metabolic syndrome and exposure to trimethyltin (TMT) are known to promote neurodegeneration. In combination the two factors may elicit additive or compensatory/regulatory mechanisms. Combined effects of TMT exposure (0.5-1 μM) and mimicked metabolic syndrome-through modulation of insulin and glucocorticoid (GC) levels-were investigated in three models: tridimensional rat brain cell cultures for neuron-glia effects; murine microglial cell line BV-2 for a mechanistic analysis of microglial reactivity; and db/db mice as an in vivo model of metabolic syndrome. In 3D cultures, low insulin condition significantly exacerbated TMT's effect on GABAergic neurons and promoted TMT-induced neuroinflammation, with increased expression of cytokines and of the regulator of intracellular GC activity, 11β-hydroxysteroid dehydrogenase 1 (11β-Hsd1). Microglial reactivity increased upon TMT exposure in medium combining low insulin and high GC. These results were corroborated in BV-2 microglial cells where lack of insulin exacerbated the TMT-induced increase in 11β-Hsd1 expression. Furthermore, TMT-induced microglial reactivity seems to depend on mineralocorticoid receptor activation. In diabetic BKS db mice, a discrete exacerbation of TMT neurotoxic effects on GABAergic neurons was observed, together with an increase of interleukin-6 (IL-6) and of basal 11β-Hsd1 expression as compared to controls. These results suggest only minor additive effects of the two brain insults, neurotoxicant TMT exposure and metabolic syndrome conditions, where 11β-Hsd1 appears to play a key role in the regulation of neuroinflammation and of its protective or neurodegenerative consequences.
AuthorsJenny Sandström, Denise V Kratschmar, Alexandra Broyer, Olivier Poirot, Philippe Marbet, Boonrat Chantong, Fanny Zufferey, Tania Dos Santos, Julien Boccard, Roman Chrast, Alex Odermatt, Florianne Monnet-Tschudi
JournalArchives of toxicology (Arch Toxicol) Vol. 93 Issue 6 Pg. 1649-1664 (06 2019) ISSN: 1432-0738 [Electronic] Germany
PMID30993381 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Cytokines
  • Glucocorticoids
  • Receptors, Glucocorticoid
  • Trimethyltin Compounds
  • trimethyltin
  • 11-beta-Hydroxysteroid Dehydrogenase Type 1
Topics
  • 11-beta-Hydroxysteroid Dehydrogenase Type 1 (biosynthesis, drug effects)
  • Animals
  • Cell Line
  • Cells, Cultured
  • Cytokines (biosynthesis)
  • Glucocorticoids (metabolism)
  • In Vitro Techniques
  • Inflammation (chemically induced, metabolism)
  • Insulin Secretion (drug effects)
  • Metabolic Syndrome (metabolism)
  • Mice
  • Mice, Inbred Strains
  • Nerve Degeneration (chemically induced, metabolism)
  • Neuroglia (drug effects)
  • Neurons (drug effects)
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, Glucocorticoid (drug effects)
  • Reproducibility of Results
  • Trimethyltin Compounds (toxicity)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: